Skip to main content
SpringerLink
Log in

MicroRNA-335 represents an independent prognostic marker in cervical cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

Advanced stages with distant metastases or recurrence lack reliable prognostic predictor for cervical cancer. Therefore, the purpose of this study was to investigate the clinical significance of miR-335 expression in cervical cancer. A total of 138 cervical cancer samples were collected, and normal cervical tissues were obtained as matched-pair controls. The level of miR-335 expression was examined using quantitative real-time polymerase chain reaction. Overall survival was analyzed using Kaplan–Meier method. Moreover, the relationship between the expression of miR-335 and the clinicopathological features was further analyzed using Cox regression. Lower miR-335 expression was found in cervical cancer specimens. Cervical cancer patients with reduced miR-335 level had shorter survival time, compared with those with high levels of miR-335 expression (P = 0.011, log-rank = 6.458). Through Cox regression, we found that miR-335 expression was associated with the survival of cervical cancer (RR = 0.251, 95 % CI 0.095–0.663, P = 0.005). The results suggested that miR-335 expression was decreased in cervical cancer specimens and lower miR-335 expression resulted in poorer survival in patients with cervical cancer. Our findings indicated that miR-335 may be a candidate factor for predicting prognosis for cervical cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.

    Article  CAS  PubMed  Google Scholar 

  2. Wei LH. Prevention and treatment of cervical cancer, it is a long-term and arduous task. Zhonghua Fu Chan Ke Za Zhi. 2013;48:304–6.

    PubMed  Google Scholar 

  3. Huang EY, Hsu HC, Sun LM, Chanchien CC, Lin H, et al. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 2011;81:1105–13.

    Article  PubMed  Google Scholar 

  4. Tsai CC, Liu YS, Huang EY, Huang SC, Chang HW, et al. Value of preoperative serum CA125 in early-stage adenocarcinoma of the uterine cervix without pelvic lymph node metastasis. Gynecol Oncol. 2006;100:591–5.

    Article  CAS  PubMed  Google Scholar 

  5. Tsai CC, Lin H, Huang EY, Huang SC, Hsieh CH, et al. The role of the preoperative serum carcinoembryonic antigen level in early-stage adenocarcinoma of the uterine cervix. Gynecol Oncol. 2004;94:363–7.

    Article  CAS  PubMed  Google Scholar 

  6. Hacker NF, Nieberg RK, Berek JS, Leuchter RS, Lucas WE, et al. Superficially invasive vulvar cancer with nodal metastases. Gynecol Oncol. 1983;15:65–77.

    Article  CAS  PubMed  Google Scholar 

  7. Pickel H, Haas J, Lahousen M. Prognostic factors in cervical cancer. Eur J Obstet Gynecol Reprod Biol. 1997;71:209–13.

    Article  CAS  PubMed  Google Scholar 

  8. Jin L, Shen Q, Ding S, Jiang W, Jiang L, et al. Immunohistochemical expression of Annexin A2 and S100A proteins in patients with bulky stage IB-IIA cervical cancer treated with neoadjuvant chemotherapy. Gynecol Oncol. 2012;126:140–6.

    Article  CAS  PubMed  Google Scholar 

  9. Li Z, Yu CP, Zhong Y, Liu TJ, Huang QD, et al. Sam68 expression and cytoplasmic localization is correlated with lymph node metastasis as well as prognosis in patients with early-stage cervical cancer. Ann Oncol. 2012;23:638–46.

    Article  CAS  PubMed  Google Scholar 

  10. Song C, Zhu S, Wu C, Kang J. Histone deacetylase (HDAC) 10 suppresses cervical cancer metastasis through inhibition of matrix metalloproteinase (MMP) 2 and 9 expression. J Biol Chem. 2013;288:28021–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Esquela-Kerscher A, Slack FJ. Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259–69.

    Article  CAS  PubMed  Google Scholar 

  12. Ronchetti D, Lionetti M, Mosca L, Agnelli L, Andronache A, et al. An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma. BMC Med Genomics. 2008;1:37.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Shu M, Zhou Y, Zhu W, Zhang H, Wu S, et al. MicroRNA 335 is required for differentiation of malignant glioma cells induced by activation of cAMP/protein kinase A pathway. Mol Pharmacol. 2012;81:292–8.

    Article  CAS  PubMed  Google Scholar 

  14. Shi L, Jiang D, Sun G, Wan Y, Zhang S, et al. miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas. J Neuro-Oncol. 2012;110:155–62.

    Article  CAS  Google Scholar 

  15. Huang HY, Cheng YY, Liao WC, Tien YW, Yang CH, et al. SOX4 transcriptionally regulates multiple SEMA3/plexin family members and promotes tumor growth in pancreatic cancer. PLoS One. 2012;7:e48637.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Heyn H, Engelmann M, Schreek S, Ahrens P, Lehmann U, et al. MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development. Int J Cancer. 2011;129:2797–806.

    Article  CAS  PubMed  Google Scholar 

  17. Dohi O, Yasui K, Gen Y, Takada H, Endo M, et al. Epigenetic silencing of miR-335 and its host gene MEST in hepatocellular carcinoma. Int J Oncol. 2013;42:411–8.

    CAS  PubMed  Google Scholar 

  18. Cao J, Cai J, Huang D, Han Q, Chen Y, et al. miR-335 represents an independent prognostic marker in epithelial ovarian cancer. Am J Clin Pathol. 2014;141:437–42.

    Article  PubMed  Google Scholar 

  19. Yan Z, Xiong Y, Xu W, Gao J, Cheng Y, et al. Identification of hsa-miR-335 as a prognostic signature in gastric cancer. PLoS One. 2012;7:e40037.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Xu Y, Zhao F, Wang Z, Song Y, Luo Y, et al. MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1. Oncogene. 2012;31:1398–407.

    Article  CAS  PubMed  Google Scholar 

  21. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12:861–74.

    Article  CAS  PubMed  Google Scholar 

  22. Jiang W, Chen X, Liao M, Li W, Lian B, et al. Identification of links between small molecules and miRNAs in human cancers based on transcriptional responses. Sci Rep. 2012;2:282.

    PubMed  PubMed Central  Google Scholar 

  23. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5:522–31.

    Article  CAS  PubMed  Google Scholar 

  24. Babashah S, Soleimani M. The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis. Eur J Cancer. 2011;47:1127–37.

    Article  CAS  PubMed  Google Scholar 

  25. Christensen BC, Moyer BJ, Avissar M, Ouellet LG, Plaza SL, et al. A let-7 microRNA-binding site polymorphism in the KRAS 3’ UTR is associated with reduced survival in oral cancers. Carcinogenesis. 2009;30:1003–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, et al. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology. 2007;72:397–402.

    Article  CAS  PubMed  Google Scholar 

  27. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006;9:189–98.

    Article  CAS  PubMed  Google Scholar 

  28. Peng HH, Zhang YD, Gong LS, Liu WD, Zhang Y. Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma. Onco Targets Ther. 2013;6:1625–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Ma J, Li N, Guarnera M, Jiang F. Quantification of plasma miRNAs by digital PCR for cancer diagnosis. Biomark Insights. 2013;8:127–36.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Yang H, Zhang C, Lu YX, Wu XJ, Yuan L, et al. Construction of has-miR-335 lentiviral vector and verification of the target gene of miR-335. Nan Fang Yi Ke Da Xue Xue Bao. 2012;32:306–11.

    CAS  PubMed  Google Scholar 

  31. Tome M, Lopez-Romero P, Albo C, Sepulveda JC, Fernandez-Gutierrez B, et al. miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Cell Death Differ. 2011;18:985–95.

    Article  CAS  PubMed  Google Scholar 

  32. Lynch J, Fay J, Meehan M, Bryan K, Watters KM, et al. MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-beta signalling pathway. Carcinogenesis. 2012;33:976–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Jiang J, Sun X, Wang W, Jin X, Bo X, et al. Tumor microRNA-335 expression is associated with poor prognosis in human glioma. Med Oncol. 2012;29:3472–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Funds

None.

Author information

Authors and Affiliations

  1. Department of Gynecology, Jining No.1 People’s Hospital, 51 Jiankang Road, Jining, Shangdong Province, 272011, China

    Changhe Wang & Tao Jiang

Authors
  1. Changhe Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tao Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tao Jiang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, C., Jiang, T. MicroRNA-335 represents an independent prognostic marker in cervical cancer. Tumor Biol. 36, 5825–5830 (2015). https://doi.org/10.1007/s13277-015-3252-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-3252-2

Keywords

Search

Navigation